PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Statin therapy may prevent cancer by blocking inflammatory protein

Study results indicate that pitavastatin inhibits interleukin-33 to suppress skin and pancreatic cancers

2024-05-30
(Press-News.org) BOSTON –  A new study led by investigators from Mass General Cancer Center, a founding member of the Mass General Brigham healthcare system, reveals that statins—commonly used cholesterol-lowering drugs—may block a particular pathway involved in the development of cancer that results from chronic inflammation. The findings are published in Nature Communications.

“Chronic inflammation is a major cause of cancer worldwide,” said senior author Shawn Demehri, MD, PhD, a principal investigator at the Center for Cancer Immunology and Cutaneous Biology Research Center of Massachusetts General Hospital and an associate professor of Dermatology at Harvard Medical School. “We investigated the mechanism by which environmental toxins drive the initiation of cancer-prone chronic inflammation in the skin and pancreas,” says Demehri, who is also the Bob and Rita Davis Family MGH Research Scholar 2023-2028. “Furthermore, we examined safe and effective therapies to block this pathway in order to suppress chronic inflammation and its cancer aftermath.”

Demehri and his colleagues’ study relied on cell lines, animal models, human tissue samples and epidemiological data. The group’s cell-based experiments demonstrated that environmental toxins (such as exposure to allergens and chemical irritants) activate two connected signaling pathways called the TLR3/4 and TBK1-IRF3 pathways. This activation leads to the production of the interleukin-33 (IL-33) protein, which stimulates inflammation in the skin and pancreas that can contribute to the development of cancer.

When they screened a library of U.S. Food and Drug Administration–approved drugs, the researchers found that a statin, pitavastatin, effectively suppresses IL-33 expression by blocking the activation of the TBK1-IRF3 signaling pathway. In mice, pitavastatin suppressed environmentally-induced inflammation in the skin and the pancreas and prevented the development of inflammation-related pancreatic cancers.

In human pancreas tissue samples, IL-33 was over-expressed in samples from patients with chronic pancreatitis (inflammation) and pancreatic cancer compared with normal pancreatic tissue. Also, in analyses of electronic health records data on more than 200 million people across North America and Europe, use of pitavastatin was linked to a significantly reduced risk of chronic pancreatitis and pancreatic cancer.

The findings demonstrate that blocking IL-33 production with pitavastatin may be a safe and effective preventive strategy to suppress chronic inflammation and the subsequent development of certain cancers.

“Next, we aim to further examine the impact of statins in preventing cancer development in chronic inflammation in liver and gastrointestinal tract and to identify other novel, therapeutic approaches to suppress cancer-prone chronic inflammation” said Demehri.

 

Authorship: Jong Ho Park, Mahsa Mortaja, Heehwa G. Son, Xutu Zhao, Lauren M. Sloat, Marjan Azin, Jun Wang, Michael R. Collier, Krishna S. Tummala, Anna Mandinova, Nabeel Bardeesy, Yevgeniy R. Semenov, Mari Mino-Kenudson, and Shadmehr Demehri.

Disclosures: Disclosure forms provided by the authors are available with the full text of this article at https://doi.org/10.1038/s41467-024-48441-8.

Funding: Research support was provided by the Burroughs Wellcome Fund, the LEO Foundation, the Sidney Kimmel Foundation, and the National Institutes of Health.

Paper cited: Park JH et al. “Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression.” Nature Communications DOI:  10.1038/s41467-024-48441-8.

###

About Massachusetts General Hospital

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. MGH is a founding member of the Mass General Brigham healthcare system.

END



ELSE PRESS RELEASES FROM THIS DATE:

A novel ‘senolytic’ strategy for treating aging-related diseases

A novel ‘senolytic’ strategy for treating aging-related diseases
2024-05-30
The process of aging is accompanied by a decline in physiological functions, which can lead to cardiovascular, neurodegenerative, and metabolic diseases. Aging of cells, also known as ‘cellular senescence’— is a process in which a cell ages and permanently stops dividing but does not die. The accumulation of such ‘senescent’ cells in tissues is then known to contribute to age-associated diseases. Elimination of senescent cells or ‘senolysis’ can, therefore, serve as an effective therapeutic strategy for the improvement of physiological function and prevention ...

Risk of death from COVID-19 lessens, but infection still can cause issues 3 years later

2024-05-30
New findings on long COVID — long-term effects on health experienced by many who have had COVID-19 — present a good-news, bad-news situation, according to a study at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care system. The bad news: COVID-19 patients who were hospitalized within the first 30 days after infection face a 29% higher risk of death in the third year compared with people who have not had the virus. However, the three-year death risk still marks a significant decline compared with such risk at the one- and two-year marks post-infection. The findings also show that even people with mild COVID-19 were still ...

Combining simulations and experiments to get the best out of Fe3Al

Combining simulations and experiments to get the best out of Fe3Al
2024-05-30
Osaka, Japan – The compound of iron and aluminum with the chemical formula Fe3Al has some very useful mechanical properties. A team from Osaka University has combined simulations with experimental techniques to better understand the kinetics of the formation of microstructures to enhance and utilize these properties and how to harness them for specific applications. In a study recently published in Acta Materialia, the researchers took an in-depth look at the way the microstructure of Fe3Al develops because the ordered domains that form contribute to one of its key properties: superelasticity. When high loads are applied to superelastic materials they ...

Both high performance and stability were achieved with multifunctional materials!

Both high performance and stability were achieved with multifunctional materials!
2024-05-30
 Through joint research with Professor Chul-jin Ahn’s team at Changwon National University, the research team of Dr. Jae-Ho Kim and Dr. Myung-kwan Song from the Department of Energy & Electronic Materials in the Surface & Nano Materials Division has developed a 4-Amino-TEMPO derivative with photocatalytic properties and successfully used it to produce high-performance and stable fiber-shaped dye-sensitized solar cells (FDSSCs) and fiber-shaped organic light-emitting diodes (FOLEDs). The developed 4-Amino-TEMPO derivative has the characteristic of simultaneously improving the performance of both fiber-shaped dye-sensitized solar cells (FDSSCs) and fiber-shaped ...

Structural inequities amplify homelessness challenges for pregnant people in Washington DC

2024-05-30
WASHINGTON -- New research conducted with Washington, DC, residents who experienced homelessness during pregnancy sheds light on the intersection of homelessness, pregnancy, and racial inequities. The findings underscore the urgent need for policy and practice changes to support vulnerable populations. The study, published May 30, 2024 in the journal Health Equity (DOI: 10.1089/heq.2023.0235), is grounded in a reproductive justice framework and delves into the lived experiences of 20 DC residents who faced homelessness while pregnant. Homelessness ...

University of Maryland study shows N95 masks near-perfect at blocking escape of airborne COVID-19

2024-05-30
COLLEGE PARK, Md. – In a head-to-head comparison of masks worn by people with active COVID-19, the inexpensive “duckbill” N95 came out on top, stopping 98% of COVID-19 particles in the breath of infected people from escaping into the air. Led by researchers from the University of Maryland School of Public Health (SPH), results showed other masks also performed well, blocking at least 70% of viral particles from escaping from the source – an infected person’s exhaled breath. The study, Relative efficacy of masks and respirators as source control for viral aerosol shedding from people infected with SARS-CoV-2, published May 29 in eBioMedicine, a Lancet ...

The AI paradox: Building creativity to protect against AI

2024-05-30
Cultivating creativity in schools is vital for a future driven by artificial intelligence (AI). But while teachers embrace creativity as an essential 21st century skill, a lack of valid and reliable creativity tests means schools struggle to assess student achievement.   Now, a new machine-learning model developed by the University of South Australia is providing teachers with access to high-quality, fit-for-purpose creativity tests, that can score assessments in a fraction of the time and a fraction of the cost.   Applied to the current ...

Visible light-induced photocatalysis–self-Fenton degradation of P-Clphoh over graphitic carbon nitride by a polyethylenimine bifunctional catalyst

Visible light-induced photocatalysis–self-Fenton degradation of P-Clphoh over graphitic carbon nitride by a polyethylenimine bifunctional catalyst
2024-05-30
The deep degradation of organic pollutants through solar light-coupled photocatalysis and the Fenton reaction (Photo-Fenton) holds significant importance in the field of water purification. In this study, a novel bifunctional catalyst (Fe-PEI-CN) was synthesized by electrostatic self-assembly and hydrothermal methods, doping graphene-like carbon nitride (CN) with polyethyleneimine (PEI) and iron (Fe) species. This catalyst efficiently degraded p-chlorophenol (p-ClPhOH) by generating hydrogen peroxide (H2O2) during the photocatalytic process. The relationship between catalytic efficiency and structure was explored using various characterization techniques.Under ...

Engineered DNA 'warhead' targets a common cancer mutation

Engineered DNA warhead targets a common cancer mutation
2024-05-30
Tumour protein P53 (TP53) plays an important role in suppressing the growth of tumours. Mutations in the gene for TP53 can have a disastrous effect, hampering the body's ability to fight tumours and even encouraging their growth. Because these are the most common mutations in cancers, TP53 has long been an interesting therapeutic target. However, efforts to destroy the mutant protein have been hampered by the difficulty of finding a way to bind to it. Now, a team of researchers from Xi'an ...

Picture this: Snapping photos of our food could be good for us

2024-05-30
New Curtin University research reveals taking pictures of food isn’t just content for our social media feeds, but could be the key to improving people’s diets.   Published in the prestigious American Journal of Clinical Nutrition, the feeding study saw researchers measure the weight of meals, which were then provided to participants over a day for breakfast, lunch and dinner.   Participants compared different technology-assisted methods to recall what they had eaten over the past 24 hours.    One method asked participants to take photos of their meals using the mobile Food Record app.   These ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Statin therapy may prevent cancer by blocking inflammatory protein
Study results indicate that pitavastatin inhibits interleukin-33 to suppress skin and pancreatic cancers